by Rod Raynovich | Aug 2, 2010 | BIOgraph
The Wall Street Journal reported on Friday that Novartis (NVS) will collaborate with Pathwork Diagnostics on the development of biomarkers across a range of cancer types that would capitalize on the trend to “match patients with the right medicines”....